Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.
Indriwanto Sakidjan Atmosudigdo,Raymond Pranata,Michael Anthonius Lim,Joshua Henrina,Emir Yonas,Rachel Vania,Rachel Vania,Basuni Radi +7 more
Reads0
Chats0
TLDR
In this article, a systematic review and meta-analysis aimed to evaluate whether dyslipidemia affects the mortality and severity of COVID-19, and also evaluated whether other comorbidities influence the association.Abstract:
Objective This systematic review and meta-analysis aimed to evaluate whether dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate whether other comorbidities influence the association. Methods A systematic literature search using PubMed, Embase, and EuropePMC was performed on 8 October 2020. This study's main outcome is a poor composite outcome, comprising of mortality and severe COVID-19. Results There were 9 studies with 3,663 patients. The prevalence of dyslipidemia in this pooled analysis was 18% (4%-32%). Dyslipidemia was associated with increased composite poor outcome (RR 1.39 [1.02, 1.88], p=0.010; I2: 56.7%, p=0.018). Subgroup analysis showed that dyslipidemia was associated with severe COVID-19 (RR 1.39 [1.03, 1.87], p=0.008; I2: 57.4%, p=0.029). Meta-regression showed that the association between dyslipidemia and poor outcome varies by age (coefficient: -0.04, p=0.033), male gender (coefficient: -0.03, p=0.042), and hypertension (coefficient: -0.02, p=0.033), but not diabetes (coefficient: -0.24, p=0.135) and cardiovascular diseases (coefficient: -0.01, p=0.506). Inverted funnel-plot was relatively symmetrical. Egger's test indicates that the pooled analysis was not statistically significant for small-study effects (p=0.206). Conclusion Dyslipidemia potentially increases mortality and severity of COVID-19. The association was stronger in patients with older age, male, and hypertension. Prospero registration number CRD42020213491.read more
Citations
More filters
Journal ArticleDOI
Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic
Vicente Javier Clemente-Suárez,Ana Isabel Beltrán-Velasco,Domingo J. Ramos-Campo,Juan Mielgo-Ayuso,Pantelis A. Nikolaidis,Noelia Belando,José Francisco Tornero-Aguilera +6 more
TL;DR: In this paper, a consensus critical review using primary sources, scientific articles, and secondary bibliographic indexes, databases, and web pages was conducted to analyze the different factors associated with physical activity that could have an impact in the COVID-19 pandemic.
Journal ArticleDOI
Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic
TL;DR: In this article , a consensus critical review using primary sources, scientific articles, and secondary bibliographic indexes, databases, and web pages was conducted to analyze the different factors associated with physical activity that could have an impact in the COVID-19 pandemic.
Journal ArticleDOI
Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2
Israel Pérez-Torres,Verónica Guarner-Lans,Elizabeth Soria-Castro,Linaloe Manzano-Pech,Adrián Palacios-Chavarría,Rafael Ricardo Valdez-Vázquez,Jose Guillermo Domínguez-Cherit,Hector Herrera-Bello,Humberto Castillejos-Suastegui,Lidia Moreno-Castañeda,Gabriela Alanís-Estrada,Fabián Hernández,Omar González-Marcos,Ricardo Márquez-Velasco,María Elena Soto +14 more
TL;DR: In this paper, the authors evaluated changes in the fatty acid (FA) profile and the participation of the activity of desaturases, in patients with severe pneumonia by SARS-CoV-2.
Journal ArticleDOI
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection.
TL;DR: The global coronavirus disease disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronivirus started in March 2020 as mentioned in this paper, and the conclusions from numerous studies indicate that people with comorbidities, such as arterial hypertension, diabetes, obesity, underlying cardiovascular disease, are particularly vulnerable to the severe course of COVID-2019.
Journal ArticleDOI
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
Sebastião Freitas de Medeiros,Márcia Marly Winck Yamamoto,Matheus Antônio Souto de Medeiros,Ana Karine Lin Winck Yamamoto,Bruna Barcelo Barbosa +4 more
TL;DR: In this paper , a comprehensive review aimed to evaluate the relationship between SARS-CoV-2 infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and endocrine characteristics frequently found in women with polycystic ovary syndrome (PCOS).
References
More filters
Journal ArticleDOI
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Jin-jin Zhang,Xiang Dong,Yi yuan Cao,Ya-dong Yuan,Yi-bin Yang,You-qin Yan,Cezmi A. Akdis,Ya-dong Gao +7 more
TL;DR: This work aims to investigate the clinical characteristic and allergy status of patients infected with SARS‐CoV‐2 and its spread around the world.
Journal ArticleDOI
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
Kelvin K. W. To,Owen Tak Yin Tsang,Wai Shing Leung,Anthony Raymond Tam,Tak Chiu Wu,David Christopher Lung,Cyril C. Y. Yip,Jian Piao Cai,Jacky Man Chun Chan,Thomas Shiu Hong Chik,Daphne Pui-Ling Lau,Chris Yau Chung Choi,Lin Lei Chen,Wan Mui Chan,Kwok-Hung Chan,Jonathan Daniel Ip,Anthony Chin-Ki Ng,Rosana W.S. Poon,Cui Ting Luo,Vincent C.C. Cheng,Jasper Fuk-Woo Chan,Jasper Fuk-Woo Chan,Ivan Hung,Zhiwei Chen,Honglin Chen,Kwok-Yung Yuen +25 more
TL;DR: The serial respiratory viral load of SARS-CoV-2 in posterior oropharyngeal saliva samples from patients with COVID-19, and serum antibody responses from patients infected with severe acute respiratory syndrome coronavirus 2 are ascertained.
Journal ArticleDOI
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
Christopher M. Petrilli,Simon Jones,Jie Yang,Harish Rajagopalan,Luke J. D. O'Donnell,Yelena Chernyak,Katie A Tobin,Robert J. Cerfolio,Fritz Francois,Leora I. Horwitz +9 more
TL;DR: Age and comorbidities were found to be strong predictors of hospital admission and to a lesser extent of critical illness and mortality in people with coronavirus disease 2019 in the United States; however, impairment of oxygen on admission and markers of inflammation were most strongly associated with critical illnesses and mortality.
Journal ArticleDOI
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.
Arthur Simonnet,Mikael Chetboun,Julien Poissy,Violeta Raverdy,Jerome Noulette,Alain Duhamel,Julien Labreuche,Daniel Mathieu,François Pattou,Mercé Jourdain +9 more
TL;DR: The COVID‐19 pandemic is rapidly spreading worldwide, notably in Europe and North America where obesity is highly prevalent and the relation between obesity and severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has not been fully documented.
Journal ArticleDOI
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.
Weerapan Khovidhunkit,Min Sun Kim,Riaz A. Memon,Judy K. Shigenaga,Arthur H. Moser,Kenneth R. Feingold,Carl Grunfeld +6 more
TL;DR: APR-induced alterations initially protect the host from the harmful effects of bacteria, viruses, and parasites, however, if prolonged, these changes in the structure and function of lipoproteins will contribute to atherogenesis.